Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Call to Schedule: 1-866-UH4-CARE
Find University Hospitals Doctors
Pierre Gholam, MD

Pierre Gholam, MD

  • Professor, CWRU School of Medicine
Meet the Provider
  • Specialty: Hepatology
  • Location:
    UH Elyria Gates Medical Center
    125 E Broad St
    Elyria, OH 44035

Biography: Pierre Gholam, MD

Expertise

  • Alcoholic Liver Disease
  • Alpha One Antitrypsin Deficiency
  • Bile Duct Cancer/ Cholangiocarcinoma
  • Drug-Induced Liver Injury
  • Hepatic Porphyrias
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma
  • Hereditary Hemochromatosis
  • Liver Cancers
  • Liver Transplantation
  • Non-Alcoholic Fatty Liver Disease
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Wilson Disease

Certifications & Memberships

  • Transplant Hepatology - American Board of Internal Medicine
  • Gastroenterology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Fellowship | Gastroenterology
Gastroenterology - Mount Sinai Morningside (1999 - 2002)

Residency | Internal Medicine
Internal Medicine - Mount Sinai Morningside (1997 - 1999)

Internship | Internal Medicine
Internal Medicine - Mount Sinai Morningside (1996 - 1997)

Medical Education
American University Of Beirut (1992 - 1996)

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Pierre Gholam disclosed the following Outside Relationships with Industry:

  • - Bayer Corporation - Consulting
  • - Onyx pharmaceuticals - Consulting
  • - Otsuka Pharmaceuticals - Consulting
  • - Vertex Pharmaceuticals - Consulting
  • - Abbvie - Honoraria
  • - Gilead Science, Inc. - Honoraria
  • - Merck & Co. Inc. - Honoraria
  • - Salix - Honoraria
  • - Abbvie - Consulting services
  • - Gilead Sciences, Inc. - Consulting services
  • - Merck & Co. Inc. - Consulting